Sanara MedTech Appoints New Directors, Director Departs
Ticker: SMTI · Form: 8-K · Filed: Sep 23, 2024 · CIK: 714256
| Field | Detail |
|---|---|
| Company | Sanara Medtech Inc. (SMTI) |
| Form Type | 8-K |
| Filed Date | Sep 23, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $350,000, $125,000, $625,000 b |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, governance
TL;DR
New blood on the board at Sanara MedTech, Collins out, Johnson & Smith in. Board shakeup!
AI Summary
Sanara MedTech Inc. announced on September 19, 2024, the departure of Director Michael J. Collins. The company also elected two new directors, David L. Johnson and Dr. David L. Smith, to its Board of Directors, effective immediately. These changes are part of the company's ongoing efforts to strengthen its governance and strategic direction.
Why It Matters
The appointment of new directors can signal a shift in company strategy or governance, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in board composition can indicate underlying issues or strategic shifts that may affect the company's future performance.
Key Players & Entities
- Sanara MedTech Inc. (company) — Registrant
- Michael J. Collins (person) — Departing Director
- David L. Johnson (person) — Newly Elected Director
- Dr. David L. Smith (person) — Newly Elected Director
- September 19, 2024 (date) — Date of earliest event reported
FAQ
Who has departed from the Board of Directors of Sanara MedTech Inc.?
Michael J. Collins has departed from the Board of Directors.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on September 19, 2024.
Who were the new directors elected to Sanara MedTech's Board?
David L. Johnson and Dr. David L. Smith were elected as new directors.
What is the exact name of the registrant?
The exact name of the registrant is Sanara MedTech Inc.
In which state was Sanara MedTech Inc. incorporated?
Sanara MedTech Inc. was incorporated in Texas.
Filing Stats: 1,017 words · 4 min read · ~3 pages · Grade level 12.3 · Accepted 2024-09-23 16:31:40
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value SMTI The Nasdaq Capital M
- $350,000 — Mr. Nixon's annual base salary will be $350,000, less applicable taxes and other legal
- $125,000 — e Board, (iii) a one-time cash bonus of $125,000 to be paid on the Company's first regul
- $625,000 b — ommon stock equal to an amount of up to $625,000 based on criteria to be established by th
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex10-1.htm (EX-10.1) — 132KB
- 0001493152-24-037820.txt ( ) — 380KB
- smti-20240919.xsd (EX-101.SCH) — 3KB
- smti-20240919_lab.xml (EX-101.LAB) — 33KB
- smti-20240919_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 23, 2024 Sanara MedTech Inc . By: /s/ Michael D. McNeil Name: Michael D. McNeil Title: Chief Financial Officer